Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics.
Read more about cookies
Implementation of paediatric precision oncology into clinical practice
nov. 2022
Karin P.S., Langenberg, et al
European Journal of Cancer
Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach
okt. 2022
Irene, Slavc, et al
Cancers
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors
sep. 2022
Lena, Blümel, et al
Cell Death and Disease
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors with Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome
sep. 2022
Martin, Hasselblatt, et al
American Journal of Surgical Pathology
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression